Chief Financial Officer
The management shakeup will slow down any hopes of a change in strategy at the kidney-dialysis company and raises questions about whether the leadership team can orchestrate a turnaround, Bloomberg Intelligence analyst
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.